You are required to be logged in to access the full website
Click here if you have forgotten your username or password
1 July 2022 - Gene and cell therapy company Oxford Biomedica plc (LSE:OXB) announced on Friday the signing of a new three-year agreement with pharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (Nasdaq:AZN).This Master Services & Developme...
1 July 2022 - Myeloid Therapeutics, Inc., a US-based clinical stage mRNA-immunotherapy company, announced on Thursday that it has added Stanley Frankel, M.D., FACP and Brett Brett Kaplan, MD to its board of directors.Dr Frankel has over 20 years of i...
1 July 2022 - Phanes Therapeutics, Inc., a US-based company involved in oncology discovery, research and clinical development, announced on Thursday that it has received orphan drug designation from the US Food and Drug Administration (FDA) for PT886...
1 July 2022 - Aristea Therapeutics, a US-based clinical-stage immunology focused drug development company advancing novel therapies to treat serious inflammatory diseases, announced on Thursday that it has dosed its first patient in the open-label ex...
1 July 2022 - Vivera Pharmaceuticals, a US-based pharmaceutical company, announced on Thursday that it has added Guido Jouret, PhD to the company's board of advisors as senior technology advisor and interim chief technology officer.Dr Jouret has...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe